BWL
VNRX icon

Bogart Wealth LLC’s VolitionRx Ltd VNRX Stock Holding History

Bogart Wealth LLC’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed – – 1207
2022
Q3 		$0 Buy
+5
New +$189 ﹤0.01% 1152

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bogart Wealth LLC's VNRX Position: Q4 2022 in Review

Bogart Wealth LLC sold out of VolitionRx Ltd (VNRX) in Q4 2022, closing a stake of 5 shares.

Bogart Wealth LLC first reported a position in VNRX in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 34 funds tracked by Wall St. Rank hold VNRX as of Q4 2022.

  • Bogart Wealth LLC reported no remaining VolitionRx Ltd position as of Q4 2022 after selling out during the quarter.
  • Bogart Wealth LLC sold 5 VolitionRx Ltd shares in Q4 2022.
  • Bogart Wealth LLC first reported a position in VolitionRx Ltd in Q3 2022 and held it in 1 quarter.
  • Bogart Wealth LLC's VolitionRx Ltd position peaked at $0 in Q3 2022.
  • 34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2022.

Based on Bogart Wealth LLC's 13F filing for Q4 2022, filed 6 Feb 2023.